Insulet is Thursday's IBD Stock Of The Day. After a wild post-earnings reaction, Insulet stock is in a consolidation with an ...

ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced ...

Insulet Corp.’s PODD groundbreaking Omnipod 5 Automated Insulin Delivery (“AID”) system (Omnipod 5) received the FDA’s approval for use by type 2 diabetes patients (ages 18 years and above). The news ...

As Americans flock to nearby orchards for festive bouts of autumn apple picking, Insulet is celebrating a particularly bountiful stateside Apple harvest itself. The diabetes devicemaker has earned FDA ...

ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced ...

The Omnipod design eliminates the tubing, consolidating the insulin reservoir and a self-inserting cannula into a single pod, less than the size of a deck of cards, which is controlled by a wireless ...

Insulet Corporation PODD recently announced the commercial introduction of its Omnipod 5 Automated Insulin Delivery System (Omnipod 5) for people with type 1 diabetes (T1D) who are two years of age ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The FDA has cleared a tubeless automated insulin ...

Insulet has alerted users of the Omnipod 5 Automated Insulin Delivery (AID) System about a potential fire hazard with the controller device's battery charger. The Medical Device Correction notice ...

Omnipod, which provides hosted instant message (IM) services to companies of all sizes, is preparing several enhancements to its platform, including the additions of a Web-based client, a telephony ...